White Papers and Resources
Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
How to build a commercialisation strategy fit for biopharma’s new evidence era
June 11, 2026 | White Papers and Resources |
The bar for evidence has never been higher. The EU’s Joint Clinical Assessment process went live in January 2025, introducing harmonised clinical evidence requirements across …
Brought to you by Nmblr
Five Predictions That Will Reshape Biopharma Commercialisation in 2026
January 5, 2026 | White Papers and Resources |
Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A …
Brought to you by Nmblr